# US 2013/0157287 A1 · Biological substance detection method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157287 A1
- Document ID: US20130157287A1
- Status: Published application
- Kind: A1
- Application number: 13/819,453
- Filed: 2011-08-30
- Published: 2013-06-20
- Earliest claimed: 2010-08-31
- Assignees: Tohoku University; Konica Minolta Medical & Graphic, Inc.
- Inventors: Kensaku Takanashi; Hideki Gouda; Hisatake Okada; Yasushi Nakano; Kohsuke Gonda; Motohiro Takeda; Noriaki Ohuchi
- Web page: https://patentgrep.com/patent/US20130157287A1

## CPC

- G01N 21/6486: {Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence)}
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/4833: {of solid biological material, e.g. tissue samples, cell cultures (tissue in vivo A61B5/00; cell suspensions G01N33/48735)}
- G01N 33/582: {with fluorescent label}
- G01N 21/6458: {Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16)}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N 2021/6441: {with two or more labels}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A biological substance detection method for detecting a biological substance specifically in a pathological specimen, comprising a step of immunologically staining the pathological specimen using a fluorescent label, a step of staining the pathological specimen with a staining reagent for morphology observation purposes (eosin) to observe the morphology of the pathological specimen, a step of irradiating the stained pathological specimen, with excited light to cause the emission of a fluorescent and detecting the biological substance in the pathological specimen. In the step of immunologically staining the pathological specimen, a special fluorescent particle for which the excitation wavelength appears in a region that is different from the excitation wavelength region of eosin is used as the fluorescent label.

## Claims

### Claim 1

A biological substance detection method of specifically detecting a biological substance in a pathological section, the method comprising;
immunostaining the pathological section with a fluorescent label;
staining the pathological section with a. staining reagent for morphological observation; and
detecting the biological substance in the pathological section through fluorescence emission by irradiation of the stained pathological section with excitation light, wherein
in the immunostaining of the pathological section, a fluorescent nanoparticle comprising phosphor or a semiconductor and having an excitation wavelength region different from an excitation wavelength region of the staining reagent is used as the fluorescent label.

### Claim 2

The biological substance detection method of specifically detecting a biological substance in a pathological section, the method comprising:
immunostaining the pathological section with a fluorescent label;
staining the pathological section with a staining reagent for morphological observation; and
detecting the biological substance in the pathological section through fluorescence emission by irradiation, of the stained pathological section with excitation light, wherein
in the immunostaining of the pathological section, a fluorescent, dye-containing particle comprising an organic or inorganic material particle containing a fluorescent dye and having an excitation wavelength region different from an excitation wavelength region of the staining reagent is used as the fluorescent label.

### Claim 3

The biological substance detection method of specifically detecting a biological substance in a pathological section, the method comprising:
immunostaining the pathological section with a fluorescent label;
staining the pathological section with a staining reagent for morphological observation; and
detecting the biological substance in the pathological section through fluorescence emission by irradiation of the stained pathological section with excitation light, wherein
in the immunostaining of the pathological section, a fluorescent nanoparticle-containing particle comprising an organic or inorganic material particle containing a fluorescent nanoparticle comprising phosphor or a semiconductor and having an excitation wavelength region different from an excitation wavelength region of the staining reagent is used as the fluorescent label.

### Claim 4 (depends on 1)

The biological substance detection method according to claim 1, wherein
in the immunostaining of the pathological section, a fluorescent label having an excitation wavelength in a wavelength region of 350 to 450 nm or in a longer wavelength region of 550 nm or more is used as the fluorescent label; and
in the staining for morphological observation of the pathological section, eosin having excitation wavelengths in a region of less than 350 nm and a wavelength region of higher than 450 nm and less than 550 nm is used as the staining reagent.

### Claim 5 (depends on 4)

The biological substance detection method according to claim 4, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 550 to 700 nm is used as the fluorescent label.

### Claim 6 (depends on 4)

The biological substance detection method according to claim 4, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 590 to 550 nm is used as the fluorescent label.

### Claim 7 (depends on 4)

The biological substance detection method according to claim 4, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 590 to 630 nm the fluorescent label.

### Claim 8 (depends on 2)

The biological substance detection method according to claim 2, wherein
the particle for containing fluorescent dye of the fluorescent dye-containing particle is composed of one or more material selected from polystyrene, polyamide, polylactic acid, polyacryionitrile, polyglycidyl methacrylate, polymelamine, polyurea, polybenzoguanamine, polyfuran, polyxylene, phenol resins, and polysaccharides.

### Claim 9 (depends on 2)

The biological substance detection method according to claim 2, wherein
the fluorescent dye of the fluorescent dye-containing particle is composed of one or more material selected from rhodamine dye molecules, BODIPY dye molecules, Texas Red dye molecules, squarylium dye molecules, cyanine dye molecules, rhodamine dye molecules, oxazine dye molecules, and carbopyronine dye molecules.

### Claim 10 (depends on 3)

The biological substance detection method according to claim 3, wherein
the fluorescent nanoparticle of the fluorescent nanoparticle-containing particle is composed of a semiconductor or an oxide phosphor.

### Claim 11 (depends on 2)

The biological substance detection method according to claim 2, wherein
in the immunostaining of the pathological section, a fluorescent label having an excitation wavelength in a wavelength region of 350 to 450 nm or in a longer wavelength region of 550 nm or more is used as the fluorescent label; and
in the staining for morphological observation of the pathological section, eosin having excitation wavelengths in a region of less than 350 nm and a wavelength region of higher than 450 nm and less than 550 nm is used as the staining reagent.

### Claim 12 (depends on 11)

The biological substance detection method according to claim 11, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 550 to 700 nm is used as the fluorescent label.

### Claim 13 (depends on 11)

The biological substance detection method according to claim 11, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 590 to 650 nm is used as the fluorescent label.

### Claim 14 (depends on 11)

The biological substance detection method according to claim 11, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 590 to 630 nm the fluorescent label.

### Claim 15 (depends on 3)

The biological substance detection method according to claim 3, wherein
in the immunostaining of the pathological section, a fluorescent label having an excitation wavelength in a wavelength region of 350 to 450 nm or in a longer wavelength region of 550 nm or more is used as the fluorescent label; and
in the staining for morphological observation of the pathological section, eosin having excitation wavelengths in a region of less than 350 nm and a wavelength region of higher than 450 nm and less than 550 nm is used as the staining reagent.

### Claim 16 (depends on 15)

The biological substance detection method according to claim 15, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 550 to 700 nm is used as the fluorescent label.

### Claim 17 (depends on 15)

The biological substance detection method according to claim 15, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 590 to 650 nm is used as the fluorescent label.

### Claim 18 (depends on 15)

The biological substance detection method, according to claim 15, wherein
in the immunostaining of the pathological section, a fluorescent label having an emission wavelength in a wavelength region of 590 to 630 nm the fluorescent label.
